Cargando…
A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
BACKGROUND: Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery of cogn...
Autores principales: | Kuut, T. A., Müller, F., Aldenkamp, A., Assmann-Schuilwerve, E., Braamse, A., Geerlings, S. E., Gibney, K. B., Kanaan, R. A. A., Nieuwkerk, P., Olde Hartman, T. C., Pauëlsen, D., Prins, M., Slieker, K., Van Vugt, M., Bleeker-Rovers, C. P., Keijmel, S. P., Knoop, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637041/ https://www.ncbi.nlm.nih.gov/pubmed/34857010 http://dx.doi.org/10.1186/s13063-021-05569-y |
Ejemplares similares
-
Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial
por: Kuut, Tanja A, et al.
Publicado: (2023) -
The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial
por: Keijmel, Stephan P, et al.
Publicado: (2013) -
A fatal case of disseminated chronic Q fever: a case report and brief review of the literature
por: Keijmel, Stephan P., et al.
Publicado: (2016) -
No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [(11)C]-PK11195
por: Raijmakers, Ruud, et al.
Publicado: (2021) -
Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands
por: Keijmel, Stephan P., et al.
Publicado: (2015)